Literature DB >> 16601971

Risks of troglitazone apparent before approval in USA.

J S Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601971     DOI: 10.1007/s00125-006-0245-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  Troglitazone: the lesson that nobody learned?

Authors:  Edwin A M Gale
Journal:  Diabetologia       Date:  2006-01       Impact factor: 10.122

2.  Hepatic dysfunction associated with troglitazone.

Authors:  P B Watkins; R W Whitcomb
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

3.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.

Authors:  P B Watkins; H J Zimmerman; M J Knapp; S I Gracon; K W Lewis
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

4.  Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.

Authors:  David J Graham; Carol R Drinkard; Deborah Shatin
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

  4 in total
  2 in total

1.  Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands.

Authors:  Stephanie N Lewis; Zulma Garcia; Raquel Hontecillas; Josep Bassaganya-Riera; David R Bevan
Journal:  J Comput Aided Mol Des       Date:  2015-01-24       Impact factor: 3.686

2.  Improving integrative searching of systems chemical biology data using semantic annotation.

Authors:  Bin Chen; Ying Ding; David J Wild
Journal:  J Cheminform       Date:  2012-03-08       Impact factor: 5.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.